DKSH Appoints Patrik Grande as new Head Business Unit Healthcare 21.11.2025, 07:00 Uhr von EQS News Jetzt kommentieren: 0

Werte zum Artikel
Name Aktuell Diff. Börse
DKSH Holding 59,25 EUR ±0,00 % L&S Exchange

DKSH Management Ltd. / Key word(s): Personnel
DKSH Appoints Patrik Grande as new Head Business Unit Healthcare

21.11.2025 / 07:00 CET/CEST


Media Release

DKSH appoints Patrik Grande as new Head Business Unit Healthcare and new member of the Executive Committee. He follows Bijay Singh who will retire after eleven years at DKSH.

Zurich, Switzerland, November 21, 2025 – DKSH today announced the appointment of Patrik Grande as new Head Business Unit Healthcare as of January 2026. Currently Vice President, Commercial Outsourcing & Cluster Head APAC, he will be a member of DKSH’s Executive Committee, report to CEO Stefan P. Butz, and will relocate from Bangkok to Singapore within the next year. Patrik Grande follows Bijay Singh who will begin his retirement on March 31, 2026, after eleven years at DKSH.

Patrik Grande is a well-seasoned and accomplished leader with more than 20 years of experience in the global pharmaceutical industry. He joined DKSH in 2022 as Vice President, Business Unit Healthcare Thailand, following a successful two-decade career at Novartis. During his time at Novartis, he held increasingly senior leadership roles across multiple markets, including South Korea, Malaysia, the United Kingdom, Switzerland, Russia, and Spain. Since joining DKSH, Patrik has revitalized the Healthcare business in Thailand and delivered growth. In his role as Vice President, Commercial Outsourcing & Cluster Head APAC, he strengthened the strategic commercial outsourcing pillar, expanded the robust regional capabilities, delivering growth and driving strategic progress across the region. A Spanish citizen, Patrik holds a Master’s degree in Business Administration from IESE Business School.

Bijay Singh leaves behind an outstanding legacy after eleven years at DKSH, including nearly nine years as Head Business Unit Healthcare and Member of the Executive Committee. Bijay Singh joined DKSH as Vice President, Global Business Development for Business Unit Healthcare in 2015. His tenure was marked by significant achievements such as building robust commercial outsourcing capabilities, driving strategic M&As, expanding the Healthcare business into new markets such as Australia, the Philippines, and South Korea, and fostering a strong talent pipeline.

Stefan P. Butz, CEO, said: “I would like to thank Bijay for his outstanding legacy at DKSH and his significant contributions to our success. I am delighted that Patrik, an exceptional internal talent, will take over as Head of Business Unit Healthcare. His appointment reflects our confidence in his capabilities, the energy and proven ability to develop talent as well as organizations, and bringing teams together to translate our vision into execution with excellence. Together with our proven leadership team, Patrik is well positioned to take our Healthcare business to the next level.”

About DKSH
For 160 years, DKSH has been delivering growth for companies in Asia and beyond across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services, following its purpose of enriching people’s lives. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 28,060 specialists, generating net sales of CHF 11.1 billion in 2024. www.dksh.com

For further information, please contact:

 

DKSH Holding Ltd.

Till Leisner

Head, Investor & Media Relations, Sustainability

Phone +41 44 386 7315 

till.leisner@dksh.com
 

Melanie Grüter

Manager, Group Media Relations
Phone +41 44 386 7211 

melanie.grueter@dksh.com



End of Media Release
View original content: EQS News


Language: English
Company: DKSH Management Ltd.
Wiesenstrasse 8
8008 Zurich
Switzerland
Phone: 044 386 72 72
E-mail: media@dksh.com
Internet: www.dksh.com
ISIN: CH0126673539
Valor: 12667353
Listed: SIX Swiss Exchange
EQS News ID: 2233872

 
End of News EQS News Service

2233872  21.11.2025 CET/CEST

Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
News-Kommentare
Thema
1 ROUNDUP/Merkel: 'Die Pandemie war eine demokratische Zumutung' Hauptdiskussion
2 Nach Reformen: Argentinien kehrt an den Finanzmarkt zurück Hauptdiskussion
3 ROUNDUP: Linke ebnet Weg zur Verabschiedung des Rentenpakets Hauptdiskussion
4 EU einig über Komplettverzicht auf Gas aus Russland Hauptdiskussion
5 Moskau erklärt Pokrowsk für erobert Hauptdiskussion
6 Trump hat sich für neuen Fed-Chef entschieden Hauptdiskussion
7 Deutschland und Polen wollen Partnerschaft vertiefen Hauptdiskussion
Alle Diskussionen
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer